Menu Back toClinical Develoment Strategy

NiFDS-DIA Workshop 2021: Facilitating the Development and Regulations of Covid-19 Vaccines and Treatments / Current Trends in New Drug Development and Regulations

The timing is as per Korean Time Zone

Clinical Develoment Strategy


Sun Young  Yum

Sun Young Yum

  • Vice President, Clinical Development Strategy
  • Bridge Biotherapeutics Inc., Korea, Republic of

Contact us

Please contact DIA Japan for further information.

Send Email